About: AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.15 (-3.59%)
AEON NYSE AEON Biopharma, Inc.
AEON Biopharma, Inc. share price
AEON price activity
Last Price
$0.160
Change (24hr)
-0.00 USD (0.82%)
Volume
785.91K
Volume (4w avg)
-
Open
$0.16
Day Range
$0.15 - $0.17
Previous Close
$0.16
Last Trade
13 Nov, 9:00 pm GMT+0
Delayed
13 Nov, 9:00 pm GMT+0
AEON price performance
Delayed
13 Nov, 9:00 pm GMT+0
AEON details
AEON Market Signals